Regulatory Strategy & Submissions

Choose the right regulatory pathway and submit with confidence

BioBoston supports regulatory strategy and submissions across drugs, biologics, devices, diagnostics, and digital health. We help you build a clear plan, align stakeholders, and deliver high quality submissions that reduce delays and support faster approvals.

  • Senior regulatory leaders across major product categories
  • Clear strategy that aligns science, quality, and business goals
  • Submission execution with disciplined content and timelines
  • Support for FDA, EMA, and global markets

Who this is for

This service is a fit if

What you’ll get

What we do

Our Regulatory Strategy and Submissions support can include:

  • Regulatory strategy development and pathway planning
  • Pre submission consulting and readiness reviews
  • Regulatory submission preparation support for IND, IDE, NDA, BLA, MAA, PMA, 510(k), and related pathways as applicable
  • Regulatory agency interaction support, including meeting preparation and follow up responses
  • Labeling and advertising compliance support where applicable
  • Post approval support for lifecycle management and regulatory updates

Why BioBoston

  • Regulatory work moves faster when the story is consistent and the plan is realistic.
  • We help you connect the science, quality, and clinical strategy into a pathway regulators can follow, while keeping internal teams aligned and reducing surprises during review.

Strategy and submission plan

We define the pathway, clarify gaps, and set a clear plan for content, owners, and timing.

Execute and support

We support drafting, review cycles, and agency interactions through submission and follow up.

Discovery call

We confirm your product type, target markets, timeline, and the decision points ahead.

How it works

Frequently Asked Questions

?
Yes. We support a broad range of product categories and tailor the pathway accordingly.

 Yes. We can review, strengthen, and harmonize content, then support final assembly and responses.

 Yes. Many clients choose continued support for lifecycle updates and regulatory changes.

Build a regulatory plan you can execute and a submission you can defend